product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Human FXR/NR1H4 Antibody
catalog :
PP-A9033A-00
quantity :
100 ug
price :
479 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
A9033A
reactivity :
human, mouse
application :
western blot, ELISA, immunohistochemistry, immunoprecipitation, immunohistochemistry - paraffin section
more info or order :
citations: 15
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - paraffin section; human; loading ...; fig s4b
Wang X, Xie C, Libby A, Ranjit S, Levi J, Myakala K, et al. The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice. J Biol Chem. 2022;298:102530 pubmed publisher
  • immunohistochemistry - paraffin section; human; 1:300; fig 1e
Nortunen M, V xe4 kiparta N, Porvari K, Saarnio J, Karttunen T, Huhta H. Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor. Virchows Arch. 2021;479:285-293 pubmed publisher
Xue T, Wang X, Pan X, Liu M, Xu F. PTX promotes breast cancer migration and invasion by recruiting ATF4 to upregulate FGF19. Cell Signal. 2024;122:111309 pubmed publisher
Hassan H, Onabote O, Isovic M, Passos D, Dick F, Torchia J. Regulation of Chromatin Accessibility by the Farnesoid X Receptor Is Essential for Circadian and Bile Acid Homeostasis In Vivo. Cancers (Basel). 2022;14: pubmed publisher
Fallon C, Smyth J, Quach A, Lajczak McGinley N, O Toole A, Barrett K, et al. Pentacyclic triterpenes modulate farnesoid X receptor expression in colonic epithelial cells: Implications for colonic secretory function. J Biol Chem. 2022;298:102569 pubmed publisher
Deng W, Fan W, Tang T, Wan H, Zhao S, Tan Y, et al. Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4. Oxid Med Cell Longev. 2022;2022:3589525 pubmed publisher
Li Q, Li N, Zeng Y, Wang X, Li J, Su H, et al. Nuclear receptor FXR impairs SK-Hep-1 cell migration and invasion by inhibiting the Wnt/β-catenin signaling pathway. Oncol Lett. 2020;20:161 pubmed publisher
Absil L, Journe F, Larsimont D, Body J, Tafforeau L, Nonclercq D. Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells. BMC Cancer. 2020;20:640 pubmed publisher
Hassan H, Isovic M, Kolendowski B, Bauer Maison N, Onabote O, Cecchini M, et al. Loss of Thymine DNA Glycosylase Causes Dysregulation of Bile Acid Homeostasis and Hepatocellular Carcinoma. Cell Rep. 2020;31:107475 pubmed publisher
Caron S, Huaman Samanez C, Dehondt H, Ploton M, Briand O, Lien F, et al. Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes. Mol Cell Biol. 2013;33:2202-11 pubmed publisher
Bhargava P, Li C, Stanya K, Jacobi D, Dai L, Liu S, et al. Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways. Nat Med. 2012;18:1665-72 pubmed publisher
Deuschle U, Schuler J, Schulz A, Schlüter T, Kinzel O, Abel U, et al. FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model. PLoS ONE. 2012;7:e43044 pubmed publisher
Prade E, Tobiasch M, Hitkova I, Schäffer I, Lian F, Xing X, et al. Bile acids down-regulate caveolin-1 in esophageal epithelial cells through sterol responsive element-binding protein. Mol Endocrinol. 2012;26:819-32 pubmed publisher
Lian F, Xing X, Yuan G, Schafer C, Rauser S, Walch A, et al. Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage. Biochem J. 2011;438:315-23 pubmed publisher
Lee J, Lee K, Lee J, Lee K, Jang K, Heo J, et al. Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion. Br J Cancer. 2011;104:1027-37 pubmed publisher
product information
brand :
R&D Systems
master code :
PP-A9033A-00
SKU :
PP-A9033A-00
product name :
Human FXR/NR1H4 Antibody
unit size :
100 ug
seo description :
The Human FXR/NR1H4 Antibody from R&D Systems is a mouse monoclonal antibody to FXR/NR1H4. This antibody reacts with human,mouse. The Human FXR/NR1H4 Antibody has been validated for the following applications: Western Blot,Immunoprecipitation,Immunohistochemistry,Immunohistochemistry-Paraffin,Direct ELISA.
target :
FXR/NR1H4
category :
Primary Antibodies
buffer :
A liquid formulation in physiologic saline with 0.1% NaN3
clonality :
Monoclonal
clone :
A9033A
conjugate :
Unconjugated
dilution :
Western Blot, Immunohistochemistry, Immunoprecipitation, Direct ELISA
host :
Mouse
immunogen :
Recombinant human FXR/NR1H4, aa 2-126
isotype :
IgG2a
purity :
Protein A or G purified from hybridoma culture supernatant
species :
Human,Mouse
specificity :
This antibody specifically recognizes human FXR and cross-reacts with rat and mouse FXR. Not yet tested in other species.
gene symbol :
NR1H4
applications :
Direct ELISA,Immunohistochemistry,Immunoprecipitation,Western Blot,Immunohistochemistry-Paraffin
USD :
479 USD
alt names :
BAR, bile acid receptor, farnesoid X receptor, Farnesoid X-activated receptor, Farnesol receptor HRR-1, FXRBAR, HRR-1, HRR1MGC163445, NR1H4, Nuclear receptor subfamily 1 group H member 4, nuclear receptor subfamily 1, group H, member 4, Retinoid X receptor-interacting protein 14, RIP14, RIP14RXR-interacting protein 14
storage :
This antibody is stable for greater than six months when held at -20 ░C in a manual defrost freezer or at -70 ░C. Upon thawing, the antibody can be stored at 2-8 ░C for at least 1 month without detectable loss of activity. Avoid repeated freeze-thaw cycles.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.